SCHEDULE 13G

Statement of Beneficial Ownership

Monte Rosa Therapeutics, Inc. Filed 2025-10-17 Acc 0001193125-25-242555

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-08-14 SCHEDULE 13G Statement of Beneficial Ownership
2025-10-17 SCHEDULE 13G Statement of Beneficial Ownership
2025-10-03 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)